Production (Stage)
Fresenius Medical Care AG
FMS
$29.02
$0.48711.71%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -0.96% | -0.60% | 0.42% | 2.26% | 3.79% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -0.96% | -0.60% | 0.42% | 2.26% | 3.79% |
| Cost of Revenue | 0.31% | 0.35% | -0.16% | 1.23% | 3.10% |
| Gross Profit | -4.70% | -3.42% | 2.18% | 5.44% | 5.89% |
| SG&A Expenses | -3.27% | -1.67% | 1.31% | 3.53% | 5.09% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -113.43% | -312.86% | -1,677.02% | -57.10% | -203.46% |
| Total Operating Expenses | -0.86% | -0.75% | -0.87% | 1.37% | 2.92% |
| Operating Income | -2.14% | 1.07% | 16.85% | 13.39% | 14.91% |
| Income Before Tax | 12.84% | 2.55% | 28.48% | -0.87% | -5.27% |
| Income Tax Expenses | 13.54% | 5.29% | 16.86% | 1.45% | 2.52% |
| Earnings from Continuing Operations | 12.55% | 1.43% | 33.65% | -1.80% | -8.14% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 17.59% | 13.07% | -1.83% | -14.36% | -13.55% |
| Net Income | 27.10% | 8.22% | 49.23% | -7.53% | -15.90% |
| EBIT | -2.14% | 1.07% | 16.85% | 13.39% | 14.91% |
| EBITDA | -6.98% | -6.26% | 1.68% | 0.07% | 3.63% |
| EPS Basic | 27.11% | 8.22% | 49.23% | -7.53% | -15.92% |
| Normalized Basic EPS | 9.30% | 10.13% | 28.39% | 15.77% | 22.28% |
| EPS Diluted | 26.81% | 7.95% | 49.50% | -7.26% | -15.60% |
| Normalized Diluted EPS | 9.30% | 10.13% | 28.39% | 15.77% | 22.28% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.02% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.02% |
| Dividend Per Share | 19.82% | 19.82% | 11.95% | 11.95% | 11.95% |
| Payout Ratio | -0.17% | -0.03% | -0.30% | 0.14% | 0.01% |